DDInter840 DDInter119
A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic and antinauseant for cancer chemotherapy patients.
Armodafinil is the enantiopure of the wakefulness-promoting agent modafinil (Provigil), and is indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy, or shift work disorder (SWD). Research has shown that armodafinil significantly improves driving simulator performance in patients with SWD. Armodafinil consists of the (−)-R-enantiomer of the racemic modafinil. Armodafinil is produced by the pharmaceutical company Cephalon Inc. (a wholly owned subsidiary of Teva Pharmaceutical Industries Ltd.) and was approved by the U.S. Food and Drug Administration (FDA) in June 2007.
Granisetron {u} (Compound) resembles {v} (Compound) Hyoscyamine
Granisetron {u} (Compound) resembles {v} (Compound) Atropine
Granisetron {u} (Compound) binds {v} (Gene) CYP3A4
Granisetron {u} (Compound) upregulates {v} (Gene) CASP10
Granisetron {u} (Compound) is included by {v} (Pharmacologic Class) Serotonin 3 Receptor Antagonists
Granisetron {u} (Compound) downregulates {v} (Gene) HSPA1A
Granisetron {u} (Compound) causes {v} (Side Effect) Hepatic enzyme increased
Granisetron {u} may cause a minor interaction that can limit clinical effects when taken with {v} Metronidazole
Granisetron {u} may cause a minor interaction that can limit clinical effects when taken with {v} Modafinil
Granisetron {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Dasatinib
Granisetron (Compound) resembles Hyoscyamine (Compound)
Granisetron (Compound) resembles Atropine (Compound)
Granisetron (Compound) binds CYP3A4 (Gene)
Granisetron (Compound) upregulates CASP10 (Gene)
Granisetron (Compound) is included by Serotonin 3 Receptor Antagonists (Pharmacologic Class)
Granisetron (Compound) downregulates HSPA1A (Gene)
Granisetron (Compound) causes Hepatic enzyme increased (Side Effect)
Granisetron may cause a minor interaction that can limit clinical effects when taken with Metronidazole
Granisetron may cause a minor interaction that can limit clinical effects when taken with Modafinil
Granisetron may cause a moderate interaction that could exacerbate diseases when taken with Dasatinib